Heterocyclic compound
TW202637178APending Publication Date: 2026-09-16TAKEDA PHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114147893
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-09
- Filing Date
- 2025-12-08
- Publication Date
- 2026-09-16
Abstract
The invention provides a compound of Formula (I), or a pharmaceutically acceptable salt thereof: wherein R1, L, R2, and R3 are as defined in the specification, for treatment of a disease, disorder or condition associated with NLRP3, including a disease, disorder or condition associated with a heterozygous gain of function mutation in the NLRP3 gene such as cryopyrin-associated periodic syndrome (CAPS).
Need to check novelty before this filing date? Find Prior Art